Biotech Companies Not Looking to Locate in L.A.

Lack of dedicated research areas and venture capital funding hampers the growth of biotech and life sciences companies in the Los Angeles area, industry officials said at a conference addressing the industry’s direction.While areas outside of the city proper, such as Thousand Oaks – home to Amgen – and the Santa Clarita Valley have attracted multiple companies, more needs to be done, said Alfred Mann, the CEO of MannKind Corp., a Valencia-based pharmaceutical firm developing drugs to treat diabetes and cancer.

MORE ON THIS TOPIC